|
To view the official press release click the following link:
Werfen Group, February 4th, 2008
Werfen Group Acquires INOVA Diagnostics
Werfen Group, S.A.,has reached a definitive agreement to acquire all of
the outstanding shares of INOVA Diagnostics, Inc., a privately held medical
diagnostics firm headquartered in San Diego, California.
INOVA is recognized as a leader in the development and manufacturing of
'in vitro' diagnostic tests for autoimmune diseases.
Recent scientific discoveries are finding autoimmune characteristics in many
of the more common diseases such as arthritis, liver disease,
atherosclerosis, celiac disease and diabetes. Some of these diseases can
affect up to one percent or more of the general population.
INOVA develops and produces first class quality new tests based on these
discoveries.
INOVA's research pipeline and scientific expertise is complementary to
Werfen's 'in vitro' test and instrumentation product line.
Werfen is excited by the growth prospects for this segment of the medical
diagnostic industry and ready to assist INOVA in realizing their growth,
expecting to keep INOVA's research, manufacturing and administrative
operations in San Diego and expand them as necessary in that area.
About Werfen Group
Werfen was founded in 1966 in Barcelona. The company manufactures and
distributes 'in vitro' medical diagnostic solutions, medical devices, and scientific
instruments worldwide. Werfen employs more than 3500 people, with 2007
revenues exceeding US$1 billion.
(Visit www.werfengroup.com for more information)
About INOVA Diagnostics
INOVA was established in San Diego in 1987. The company develops and
manufactures 'in vitro' medical diagnostic tests for autoimmune disease that are
used in medical labs, hospitals and universities around the world. The company
employs 160 people at its San Diego facility.
(Visit www.inovadx.com for more information) |
